CHU Toulouse
Toulouse, 31059, France
NCT Number: NCT02703038
Cardiogenic shock (CS) is defined as an organ hypoperfusion secondary to low cardiac output. Catches diagnostic management, and therapeutic monitoring of these patients remain highly variable from one center to another and even from one doctor to another within the same team. The management protocols are often not standardized or non-existent.
It appears therefore necessary to make an inventory of the management practices of the CS in France in 2016, prerequisite to a common work of standardization of practices and the creation of specialized networks to support these complex patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Toulouse, 31059, France
The Observatory FRENSHOCK proposes to set up a cohort of 500 patients recruited prospectively over a period of 6 months.
Patients will be followed up at 1 month and 1 year Patients should have agreed to participate in the observatory, knowing that participation or refusal to participate will not alter the therapeutic attitude of the physician responsible for the patient. The study of phenotypic characteristics will not change the therapeutic approach of the medical teams.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(A) Low cardiac output (1 criterion necessary and sufficient):
(C) Organs malperfusion (1 criterion necessary and sufficient):
Exclusion criteria
Time frame: 30 days
Death rate at 30 days of follow-up
Time frame: 30 days
Rate of mortality at day 30 distributed by subgroup on age, sex, NYHA grade, initial etiology (Including ischemic versus non-ischemic heart disease, type and assistance and medical treatment)
Time frame: 1 year
Death rate at 1 year of follow-up
French Cardiology Society
Other
Acronym: FRENSHOCK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03714048
Arrhythmias, Cardiac, Blood Coagulation Disorders
Sydney, New South Wales, Australia
View Trial DetailsNCT03327493
Autonomic Nervous System Diseases, Cardiovascular Diseases
Nancy, France
View Trial DetailsNCT02697006
Cardiovascular Diseases, Heart Diseases
Bad Nauheim, Hesse, Germany
View Trial DetailsNCT04202432
Cardiac Failure, Cardiovascular Diseases
Eindhoven, North Brabant, Netherlands
View Trial Details